<DOC>
	<DOC>NCT02039765</DOC>
	<brief_summary>To characterize the plasma pharmacokinetics and safety profile of brimonidine following a single dose and 4 times per day (QID) dosing of brimonidine tartrate ophthalmic solution 0.025% for 7 days in healthy, adult subjects.</brief_summary>
	<brief_title>Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.</brief_title>
	<detailed_description />
	<mesh_term>Hyperemia</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>have ocular health within normal limits. have blood (hematology, blood chemistry) and urine analysis within normal limits. have a body weight within 15% of ideal weight have known contraindications or sensitivity to the use of any of the investigational drug(s) or their components, or any other medications required by the protocol; have any active systemic or ocular disorder other than refractive disorder. have presence of any abnormality of the lids, ocular surface, or lacrimal duct system that in the Investigator's opinion could affect ophthalmic drop absorption. have a history of chronic alcohol consumption. consume alcohol and/or caffeine or xanthine containing products within 48 hours prior to dosing at Visit 1 or anticipated use during the study. have a history of tobacco, nicotine, or nicotine containing product use within the last year prior to Visit 2; have significant weight change (over 10 pounds) within the 60 days prior to Visit 2; have blood donation or equivalent blood loss of 450 ml or more, within 60 days prior to Visit 2; have an abnormal blood pressure (defined as ≤ 90 or ≥ 160 (systolic) measured in mmHg or ≤ 60 or ≥ 100 (diastolic) measured in mmHg); have intraocular pressure (IOP) that is less than 5 mmHg or greater than 22 mmHg or have a normal IOP with a diagnosis of glaucoma.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Ocular Redness</keyword>
</DOC>